ProfileGDS4718 / 202723_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 91% 85% 91% 85% 78% 82% 87% 90% 87% 88% 90% 85% 83% 80% 90% 85% 70% 73% 70% 89% 87% 87% 85% 89% 83% 86% 78% 86% 76% 74% 76% 87% 89% 83% 84% 79% 89% 86% 88% 82% 80% 83% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6672386
GSM549102patient 115, normal, homogenized [OPG study]9.2809491
GSM549104patient 119, normal, homogenized [OPG study]8.5371385
GSM549108patient 138, normal, homogenized [OPG study]9.2513491
GSM549119patient 077, normal, homogenized [OPG study]8.4572685
GSM549133patient 032, cancer, homogenized [OPG study]7.7472478
GSM549139patient 042, cancer, homogenized [OPG study]8.0588182
GSM549099patient 107, normal, homogenized [OPG study]8.6819287
GSM549109patient 139, normal, homogenized [OPG study]9.280890
GSM549110patient 046, normal, homogenized [OPG study]8.7922287
GSM549114patient 063, normal, homogenized [OPG study]8.9620688
GSM549122patient 082, normal, homogenized [OPG study]9.2088790
GSM549134patient 033, cancer, homogenized [OPG study]8.4609585
GSM549136patient 036, cancer, homogenized [OPG study]8.2686383
GSM549140patient 044, cancer, homogenized [OPG study]7.947880
GSM549111patient 047, normal, homogenized [OPG study]9.2146590
GSM549113patient 057, normal, homogenized [OPG study]8.6323385
GSM549132patient 031, cancer, homogenized [OPG study]6.9099970
GSM549137patient 038, cancer, homogenized [OPG study]7.1520373
GSM549142patient 047, cancer, homogenized [OPG study]6.8678470
GSM549100patient 110, normal, homogenized [OPG study]8.993589
GSM549107patient 135, normal, homogenized [OPG study]8.7806587
GSM549115patient 068, normal, homogenized [OPG study]8.9163287
GSM549116patient 072, normal, homogenized [OPG study]8.5678185
GSM549120patient 078, normal, homogenized [OPG study]8.981389
GSM549131patient 030, cancer, homogenized [OPG study]8.3459483
GSM549118patient 074, normal, homogenized [OPG study]8.6761886
GSM549129patient 027, cancer, homogenized [OPG study]7.7017978
GSM549123patient 088, normal, homogenized [OPG study]8.5564286
GSM549124patient 006, cancer, homogenized [OPG study]7.3771676
GSM549126patient 015, cancer, homogenized [OPG study]7.285474
GSM549128patient 025, cancer, homogenized [OPG study]7.5439876
GSM549103patient 117, normal, homogenized [OPG study]8.6399987
GSM549117patient 073, normal, homogenized [OPG study]9.2592789
GSM549138patient 041, cancer, homogenized [OPG study]8.1876883
GSM549141patient 045, cancer, homogenized [OPG study]8.4614184
GSM549130patient 028, cancer, homogenized [OPG study]7.7455679
GSM549101patient 111, normal, homogenized [OPG study]8.9830389
GSM549105patient 128, normal, homogenized [OPG study]8.588586
GSM549106patient 134, normal, homogenized [OPG study]9.0950288
GSM549112patient 048, normal, homogenized [OPG study]8.0556782
GSM549125patient 011, cancer, homogenized [OPG study]7.8257280
GSM549127patient 024, cancer, homogenized [OPG study]8.2192683
GSM549135patient 035, cancer, homogenized [OPG study]8.0528381